Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PEA Ingredient Improves Exercise Performance: Clinical Study - Nutraceuticals World

What are you searching for?

Sign in
Market Updates, Research

PEA Ingredient Improves Exercise Performance: Clinical Study

Gencor’s Levagen+ was associated with a 17% greater improvement in lower body power, and 5% greater improvement in isometric strength, compared to placebo.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

A new human clinical study found that a PEA ingredient marketed by Gencor as Levagen+ may help to improve exercise performance. The findings were published in Sports Medicine.

According to the authors of the study, supplements with inflammatory-modulating properties might be more suitable than over-the-counter medications for managing healthy inflammatory response, as over-the-counter medications may negatively impact skeletal muscle adaptations.

The study assessed either daily Levagen+ supplementation or treatment with a placebo for eight weeks, concurrent with an eight-week strength training protocol in 52 healthy, active women.

A daily dose of 350 mg of PEA significantly improved lower body power and isometric strength compared to the placebo group, by 17% and 5% respectively. There were no inhibitions observed in any measured strength training adaptations compared to the placebo group, unlike what is typically seen with the use of non-steroidal anti-inflammatory drugs (NSAIDs).

“To our knowledge, this is the first study to investigate the effects of PEA on the adaptive responses to strength training, and it is a great honor to have this data published in the Sports Medicine Journal,” said R.V. Venkatesh, co-founder and managing director at Gencor. “This is our second study investigating Levagen+ for active nutrition, and it continues to show great promise in this category.”

Levagen+ is a highly bioavailable form of PEA, formulated with Pharmako Biotechnologies’ LipiSperse. It has been studied for applications in joint health, sleep support, exercise recovery, immune health, and supporting a healthy inflammation response.  

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics